Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Relevare Pharmaceuticals Ltd.
DescriptionSodium channel antagonist
Molecular Target
Mechanism of ActionNa channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic and inflammatory pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today